BUCHDUNGER; Elisabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUCHDUNGER; Elisabeth.The latest application filed is for "use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis".

Company Profile

0.4.11

BUCHDUNGER; Elisabeth - Neuenburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis App 20130267549 - BUCHDUNGER; Elisabeth ; et al.	2013-10-10
Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. App 20120283206 - Bruns; Christian ; et al.	2012-11-08
Inhibitors Of The Mutant Form Of Kit App 20120157441 - Buchdunger; Elisabeth ; et al.	2012-06-21
Inhibitors of the mutant form of kit Grant 8,124,611 - Buchdunger , et al. February 28, 2	2012-02-28
Inhibitors of the mutant form of kit Grant 8,017,621 - Buchdunger , et al. September 13, 2	2011-09-13
Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis App 20110124670 - Buchdunger; Elisabeth ; et al.	2011-05-26
Inhibitors Of The Mutant Form Of Kit App 20100179179 - Buchdunger; Elisabeth ; et al.	2010-07-15
Combination comprising a signal transduction inhibitor and an epothilone derivative Grant 7,723,339 - Brandt , et al. May 25, 2	2010-05-25
Combination Comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-p- Yridyl)-2pyrimidine-amine And A Chemotherapeutic Agent App 20090202541 - Bruns; Christian ; et al.	2009-08-13
Inhibitors of the Mutant Form of Kit App 20070213317 - Buchdunger; Elisabeth ; et al.	2007-09-13
Treatment of gastrointestinal stromal tumors Grant 6,958,335 - Buchdunger , et al. October 25, 2	2005-10-25
Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-- 2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent App 20040167134 - Bruns, Christian ; et al.	2004-08-26
Combination comprising a signal transduction inhibitor and an epothilone derivative App 20040132754 - Brandt, Ralf ; et al.	2004-07-08
Treatment of gastrointestinal stromal tumors App 20040023976 - Buchdunger, Elisabeth ; et al.	2004-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.